Login / Signup

The Low-Risk Profile in Pulmonary Arterial Hypertension. Time for a Paradigm Shift to Goal-oriented Clinical Trial Endpoints?

Jason WeatheraldAthénaïs BouclyAdriano R TonelliMarc HumbertOlivier Sitbon
Published in: American journal of respiratory and critical care medicine (2019)
Keyphrases
  • pulmonary arterial hypertension
  • clinical trial
  • pulmonary artery
  • pulmonary hypertension
  • phase ii
  • open label
  • double blind
  • study protocol
  • phase iii
  • randomized controlled trial